Hysoft Moisturizing Cream contains Hydrocortisone 0.1% w/w, a low-potency topical corticosteroid indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. This formulation is designed to provide effective anti-inflammatory, antipruritic, and vasoconstrictive actions, thereby reducing redness, swelling, and itching associated with conditions such as eczema, dermatitis, insect bites, and allergic reactions. The moisturizing base of Hysoft Cream aids in restoring the skin’s natural barrier function and hydration, enhancing patient comfort during treatment. It is intended for external use only and should be applied sparingly to the affected area, typically two to three times daily, or as directed by a healthcare professional. Prolonged use or application over large surface areas should be avoided to minimize the risk of systemic absorption and potential corticosteroid-related adverse effects. Caution is advised in patients with skin infections, as corticosteroids may exacerbate these conditions. Hysoft Moisturizing Cream is contraindicated in individuals with hypersensitivity to hydrocortisone or any component of the formulation. Patients should consult a physician if symptoms persist beyond seven days or worsen during treatment. This product is not recommended for use in children under two years of age without medical supervision.